Modelling A.I. in Economics

Optum's Offer for Amedisys Could Shake Up the Healthcare Industry

Amedisys, Inc. (AMED) announced on Monday that it had received an unsolicited $3.26 billion all-cash offer from UnitedHealth Group's (UNH) health services company Optum. The offer, which is at a premium of 22% to Amedisys's closing price on Friday, comes a month after Amedisys agreed to be bought by another healthcare firm, Option Care Health Inc. (OCLH).

Optum's offer is worth $100 per share in cash. Amedisys said its board of directors will review the offer and make a recommendation to shareholders.

Amedisys provides home health, hospice, and personal care services in the United States. The company has 12,000 employees and serves more than 50,000 patients.

Optum is a leading health services company that provides a variety of services, including pharmacy, vision, and behavioral health. The company has more than 170,000 employees and serves more than 100 million people.

The acquisition of Amedisys would be a major expansion for Optum's home health and hospice businesses. It would also give Optum a larger presence in the southern United States, where Amedisys is based.

It is not yet clear whether Option Care Health will match Optum's offer. Option Care Health's offer is worth $75 per share in cash and stock.

Amedisys shareholders have until June 19 to tender their shares to Option Care Health.

People also ask

⚐ What are the top stocks to invest in right now?
☵ What happens to stocks when they're delisted?
This project is licensed under the license; additional terms may apply.